Skip to main content
OpenTrials

Clinical trial condition

Dermatitis Atopic

Explore clinical trials studying Dermatitis Atopic. Study availability and eligibility vary by location and protocol.

21 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis Atopic trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

NCT06241118

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • University of Alabama at Birmingham- Site Number : 8401267 Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Arkansas Dermatology - North Little Rock- Site Number : 8401244 North Little Rock, Arkansas, United States
  • Encino Research Center- Site Number : 8401042 Encino, California, United States
View all 150 locations
View Trial Details
Recruiting

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

NCT06192563

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Investigational Site Number: 002 Bologna, Italy
  • Investigational Site Number: 006 Brescia, Italy
  • Investigational Site Number: 004 Florence, Italy
  • Investigational Site Number: 001 Milan, Italy
View Trial Details
Enrolling by Invitation

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT05492578

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Allervie Clinical Research - Birmingham- Site Number : 8401101 Birmingham, Alabama, United States
  • Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale, Arizona, United States
View all 390 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT06130566

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale, Arizona, United States
  • First OC Dermatology- Site Number : 8401025 Fountain Valley, California, United States
  • Center for Dermatology Clinical Research- Site Number : 8401018 Fremont, California, United States
  • Sunwise Clinical Research- Site Number : 8401022 Lafayette, California, United States
View all 148 locations
View Trial Details
Completed

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

NCT03849716

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • C Squared Research Center Site Number : 8400068 Birmingham, Alabama, United States
  • Cahaba Dermatology Site Number : 8400046 Birmingham, Alabama, United States
  • C2 Research Center, LLC Site Number : 8400071 Montgomery, Alabama, United States
  • Axis Clinical Trials Site Number : 8400025 Los Angeles, California, United States
View all 48 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

NCT06790121

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • T. Joseph Raoof MD Inc-Site Number: 8400004 Encino, California, United States
  • Integrative Skin Science and Research-Site Number: 8400002 Sacramento, California, United States
  • Clinical Trials Research Institute-Site Number: 8400003 Thousand Oaks, California, United States
  • Skin Care Research-Site Number: 8400013 Boca Raton, Florida, United States
View all 52 locations
View Trial Details
Completed

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

NCT06015308

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Clinical Research Center of Alabama - Homewood- Site Number : 8401101 Birmingham, Alabama, United States
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Orange County Clinical Trials- Site Number : 8401271 Anaheim, California, United States
  • First OC Dermatology- Site Number : 8401025 Fountain Valley, California, United States
View all 57 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

NCT06181435

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States
  • Eclipse Clinical Research- Site Number : 8401158 Tucson, Arizona, United States
  • Torrance Clinical Research- Site Number : 8401027 Lomita, California, United States
  • Dermatology Research Associates - Los Angeles- Site Number : 8401092 Los Angeles, California, United States
View all 142 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

NCT06224348

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States
  • Johnson Dermatology- Site Number : 8401076 Fort Smith, Arkansas, United States
  • Encino Research Center- Site Number : 8401042 Encino, California, United States
  • Marvel Clinical Research- Site Number : 8401102 Huntington Beach, California, United States
View all 167 locations
View Trial Details

Related conditions